Neurofibrillary tangles and tau phosphorylation

被引:0
|
作者
Brion, JP
Anderton, BH
Authelet, M
Dayanadan, R
Leroy, K
Lovestone, S
Octave, JN
Pradier, L
Touchet, N
Tremp, G
机构
[1] Free Univ Brussels, Lab Histol Neuroanat & Neuropathol, B-1070 Brussels, Belgium
[2] Kings Coll London, Inst Psychiat, Dept Neurosci, London SE5 8AF, England
[3] Catholic Univ Louvain, Pharmacol Lab, B-1200 Brussels, Belgium
[4] Rhone Poulenc Rorer, Ctr Rech Vitry Alfortville, F-94403 Vitry Sur Seine, France
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurofibrillary tangles (NFTs) are a characteristic neuropathological lesion of Alzheimer's disease (AD). They are composed of a highly-phosphorylated form of the microtubule-associated protein tau. We are investigating the relationship between NFTs and microtubule stability and how tau phosphorylation and function is affected in transgenic models and by co-expression with beta -amyloid precursor protein and presenilins. In most NFT-bearing neurons, we observed a strong reduction in acetylated a-tubulin immunoreactivity (a marker of stable microtubules) and a reduction of the in situ hybridization signal for tubulin mRNA. In transfected cells, mutated tau forms (corresponding to tau mutations identified in familial forms of frontotemporal dementias linked to chromosome 17) were less efficient in their ability to sustain microtubule growth. These observations are consistent with the hypothesis that destabilization of the microtubule network is an important mechanism of cell dysfunction in Alzheimer's disease. The glycogen synthase kinase-3 beta (GSK-3 beta) generates many phosphorylated sites on tau. We performed a neuroanatomical study of GSK-3 beta distribution showing that developmental evolution of GSK-3 beta compartmentalization in neurons paralleled that of phosphorylated tau. Studies on transfected cells and on cultured neurons showed that GSK-3 beta activity controls tau phosophorylation and tau functional interaction with microtubules. Tau phosphorylation was not affected in neurons overexpressing B -amyloid precursor protein. Transgenic mice expressing a human tau isoform and double transgenic animals for tau and mutated presenilin 1 have been generated; a somatodendritic accumulation of phosphorylated transgenic tau proteins, as observed in the pretangle stage in AD, has been observed but NFTs were not found, suggesting that additional factors might be necessary to induce their formation.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 50 条
  • [31] Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation
    Tanabe, Y
    Ishizu, H
    Ishiguro, K
    Itoh, N
    Terada, S
    Haraguchi, T
    Kawai, K
    Kuroda, S
    [J]. NEUROREPORT, 2000, 11 (11) : 2473 - 2477
  • [32] Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
    Gamblin, TC
    Chen, F
    Zambrano, A
    Abraha, A
    Lagalwar, S
    Guillozet, AL
    Lu, ML
    Fu, YF
    Garcia-Sierra, F
    LaPointe, N
    Miller, R
    Berry, RW
    Bincler, LI
    Cryns, VL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (17) : 10032 - 10037
  • [33] Fluent molecular mixing of Tau isoforms in Alzheimer's disease neurofibrillary tangles
    Dregni, Aurelio J.
    Duan, Pu
    Xu, Hong
    Changolkar, Lakshmi
    El Mammeri, Nadia
    Lee, Virginia M-Y
    Hong, Mei
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [34] NEUROFIBRILLARY TANGLES AND PARKINSONISM
    SUDHAKAR, S
    RAJPUT, AH
    ROZDILSKY, B
    UITTI, RJ
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : A114 - A114
  • [35] Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles
    Iqbal, K
    Alonso, AD
    Gong, CX
    Khatoon, S
    Pei, JJ
    Wang, JZ
    Grundke-Iqbal, I
    [J]. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (53): : 169 - 180
  • [36] Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1
    Boutajangout, A
    Leroy, K
    Touchet, N
    Authelet, M
    Blanchard, V
    Tremp, G
    Pradier, L
    Brion, JP
    [J]. NEUROSCIENCE LETTERS, 2002, 318 (01) : 29 - 33
  • [37] NONENZYMATIC GLYCATION OF TAU IN NEUROFIBRILLARY TANGLES OF ALZHEIMERS-DISEASE - A MECHANISM FOR AGGREGATION AND NEUROTOXICITY
    YAN, SD
    CHEN, X
    SCHMIDT, AM
    BRETT, J
    CAPUTO, C
    SCOTT, C
    YEN, SH
    STERN, D
    [J]. NEUROLOGY, 1994, 44 (04) : A371 - A372
  • [38] Tau pathology in aging and AD: beyond neurofibrillary tangles (grains, astrocytes, etc.)
    Alafuzoff, I
    [J]. BRAIN PATHOLOGY, 2014, 24 : 20 - 21
  • [39] Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice
    Bian, F
    Nath, R
    Sobocinski, G
    Booher, RN
    Lipinski, WJ
    Callahan, MJ
    Pack, A
    Wang, KKW
    Walker, LC
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 2002, 446 (03) : 257 - 266
  • [40] Preclinical characterization of two promising PET tracers for imaging tau neurofibrillary tangles (NFTs)
    Mugnaini, M.
    Skaddan, M. B.
    Guo, Q.
    Wilcox, K.
    Reuter, D. M.
    Voorbach, M.
    Haupt, A.
    Geneste, H.
    Erhard, T.
    Tovcimak, A.
    Finnema, S.
    Martarello, L.
    Comley, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S141 - S142